ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

RGD Peptide Modified Erythrocyte Membrane/Porous Nanoparticles Loading Mir-137 for NIR-Stimulated Theranostics of Glioblastomas

Li, Minghui; Cui, Xinyu; Wei, Feng; Li, Chao; Han, Xiaojun*哈尔滨医科大学
Nanomaterials2022-5DOI: 10.3390/nano12091464
6被引5阅读
引用收藏
分享

摘要

Cell-derived drug carriers have increasingly gained the interest of the scientific community due to their ability to imitate various natural properties of their source cells. We developed theranostics nanoplatforms composed of mesoporous silica nanoparticles (MSNs), indocyanine green (ICG) molecules, microRNAs-137 (miR-137), red-blood-cell membranes (RM), and tumor-targeting cyclo Arg-Gly-Asp-d-Phe-Cys peptides (cRGD(fC)), which were abbreviated as MSNs/ICG/miR/RM/RGD particles. These particles possessed photothermal and gene therapy properties due to ICG and miR-137, respectively. The photothermal conversion efficiency was similar to 18.7%. Upon 808 nm light irradiation, the tumor inhibition rate reached 94.9% with dosage of 10 mg/kg. The developed nanoplatform possessed unique properties, such as exceptional biocompatibility, immune escaping, and specific recognition, which was also used for near-infrared fluorescence, photoacoustic (PA) bimodal imaging-guided tumor recognition.

学科与关键词

关键词
mesoporous silicaindocyanine greenmicroRNAs-137red blood cell membranesglioblastomassynergistic treatment
相关
加载中…
  • A cancer cell membrane coated, doxorubicin and microRNA co-encapsulated nanoplatform for colorectal cancer theranostics
    Zhu, Sihao; Li, Ziyuan; Zheng, Dongye; Yu, Yue; Xiang, Jing; Ma, Xiao; Xu, Dongqing; Qiu, Jiajun; Yang, Ziyu; Wang, Zhiyi; Li, Jun; Sun, Hongfang; Chen, Weiqiang; Meng, Xiangxi*; Lu, Yanye*; Ren, Qiushi*Molecular Therapy-Oncolytics, 2023, 28: 182-196.被引 3
  • Macrophage-Mediated Porous Magnetic Nanoparticles for Multimodal Imaging and Postoperative Photothermal Therapy of Gliomas
    Wang, Sheng; Shen, Hailin; Mao, Qiulian; Tao, Qing; Yuan, Guotao; Zeng, Lingli; Chen, Ziying; Zhang, Yunjiao; Cheng, Liang; Zhang, Jingzhong; Dai, Hui*; Hu, Chunhong*; Pan, Yue*; Li, Yonggang*ACS applied materials & interfaces, 2021, 13(48): 56825-56837.被引 21
  • Recent Research Progress of RGD Peptide-Modified Nanodrug Delivery Systems in Tumor Therapy
    Yin, Liyan; Li, Xingchen; Wang, Rongrong; Zeng, Yiying; Zeng, Zhaowu*; Xie, Tian*International Journal of Peptide Research and Therapeutics, 2023, 29(4): 53.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Nanomaterials
发表日期
2022-05
卷期
第 12 卷, 第 9 期
页码
1464
DOI
10.3390/nano12091464
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22174031]; Fundamental Research Funds for the Central Universities [HIT.OCEF.2021026]; Yu Wei Han Academician Outstanding Youth Development Fund [DQYWH201603]; National Natural Science Foundation of Heilongjiang Province [LH2021H114]

作者

  • L

    Li, Minghui (第一作者)

    harbin inst technol · harbin med univ

  • C

    Cui, Xinyu

    mudanjiang med univ

查看全部 5 位作者收起作者
  • W

    Wei, Feng

    harbin inst technol

  • L

    Li, Chao

    harbin inst technol

  • H

    Han, Xiaojun (通讯)

    harbin inst technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417